vimarsana.com
Home
Live Updates
Oncorenas first patient treated with ONC175 (orellanine) in clinical phase I/II trial in patients with metastatic renal cancer and dialysis at Karolinska University Hospital in Stockholm, Sweden : vimarsana.com
Oncorena's first patient treated with ONC175 (orellanine) in clinical phase I/II trial in patients with metastatic renal cancer and dialysis at Karolinska University Hospital in Stockholm, Sweden
/PRNewswire/ -- Oncorena announces first patient treated in the Phase I/II trial of the first-in-class compound, ONC175 (orellanine), in patients with...
Related Keywords
Sweden ,
Stockholm ,
Gothenburg ,
Vastra Gotalands Lan ,
Swedish ,
Prnewswire Oncorena ,
Jeffrey Yachnin ,
Data Review Committee ,
University Of Gothenburg ,
Centre For Clinical Cancer ,
Sweden Innovation Agency ,
Clinical Cancer Studies At Karolinska University Hospital ,
Karolinska University Hospital ,
Clinical Cancer ,
Clinical Cancer Studies ,
Karolinska University ,
Press Release ,
Innovation Agency ,
Oncorena Ab ,
vimarsana.com © 2020. All Rights Reserved.